B cell lymphoma 10 is essential for FcεR-mediated degranulation and IL-6 production in mast cells

Journal of Immunology

Volumn 178, Issue 1, 2007, Pages 49-57

  Chen, Yuhong ^a   Pappu, Bhanu P ^b   Zeng, Hu ^a   Xue, Liquan ^c   Morris, Stephan W ^c   Lin, Xin ^b   Wen, Renren ^a   Wang, Demin ^a,d,e  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CALCIUM; FC RECEPTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 10; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CALCIUM TRANSPORT; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVATION; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PASSIVE SKIN ANAPHYLAXIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR UPREGULATION; T LYMPHOCYTE;

EID: 33845917204     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.1.49     Document Type: Article

References (70)

1. Galli, S. J., J. Kalesnikoff, M. A. Grimbaldeston, A. M. Piliponsky, C. M. M. Williams, and M. Tsai. 2005. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 23: 749-786.
2. Galli, S. J., S. Nakae, and M. Tsai. 2005. Mast cells in the development of adaptive immune responses. Nat. Immunol. 6: 135-142.
3. Galli, S. J., K. M. Zsebo, and E. N. Geissler. 1994. The kit ligand, stem cell factor, Adv. Immunol. 55: 1-96.
4. Kitamura, Y., S. Go, and K. Hatanaka. 1978. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood 52: 447-452.
5. Galli, S. J., and Y. Kitamura. 1987. Genetically mast-cell-deficient W/Wv and Sl/Sld mice: their value for the analysis of the roles of mast cells in biologic responses in vivo. Am. J. Pathol. 127: 191-198.
6. Ravetch, J. V., and R. A. Clynes. 1998. Divergent roles for Fc receptors and complement in vivo. Annu. Rev. Immunol. 16: 421-432.
7. Daeron, M. 1997. Fc receptor biology. Annu. Rev. Immunol. 15: 203-234.
8. Eiseman, E., and J. B. Bolen. 1992. Engagement of the high-affinity IgE receptor activates src protein-related tyrosine kinases. Nature 355: 78-80.
9. syk in high affinity IgE receptor signaling: identification as a component of pp72 and association with the receptor γ chain after receptor aggregation. J. Biol. Chem. 268: 23318-23324.
10. Saitoh, S., R. Arudchandran, T. S. Manetz, W. Zhang, C. L. Sommers, P. E. Love, J. Rivera, and L. E. Samelson. 2000. LAT is essential for FcεRI-mediated mast cell activation. Immunity 12: 525-535.
11. Pivniouk, V. I., T. R. Martin, J. M. Lu-Kuo, H. R. Katz, H. C. Oettgen, and R. S. Geha. 1999. SLP-76 deficiency impairs signaling via the high-affinity IgE receptor in mast cells. J. Clin. Invest. 103: 1737-1743.
12. Brdicka, T., M. Imrich, P. Angelisova, N. Brdickova, O. Horvath, J. Spicka, I. Hilgert, P. Luskova, P. Draber, P. Novak, et al. 2002. Non-T cell activation linker (NTAL): a transmembrane adaptor protein involved in immunoreceptor signaling. J. Exp. Med. 196: 1617-1626.
13. Xie, Z.-H., I. Ambudkar, and R. P. Siraganian. 2002. The adapter molecule Gab2 regulates FcεRI-mediated signal transduction in mast cells. J. Immunol. 168: 4682-4691.
14. Rhee, S. G., and Y. S. Bae. 1997. Regulation of phosphoinositide-specific phospholipase C isozymes. J. Biol. Chem. 272: 15045-15048.
15. Koyasu, S. 2003. The role of PI3K in immune cells. Nat. Immunol. 4: 313-319.
16. Chao, T. S., D. A. Foster, U. R. Rapp, and M. R. Rosner. 1994. Differential Raf requirement for activation of mitogen-activated protein kinase by growth factors, phorbol esters, and calcium. J. Biol. Chem. 269: 7337-7341.
17. Hirasawa, N., F. Santini, and M. A. Beaven. 1995. Activation of the mitogen-activated protein kinase/cytosolic phospholipase A2 pathway in a rat mast cell line: indications of different pathways for release of arachidonic acid and secretory granules. J. Immunol. 154: 5391-5402.
18. Roa, M., F. Paumet, J. Le Mao, B. David, and U. Blank. 1997. Involvement of the ras-like GTPase rab3d in RBL-2H3 mast cell exocytosis following stimulation via high affinity IgE receptors (FcεRI). J. Immunol. 159: 2815-2823.
19. Jiang, A., A. Craxton, T. Kurosaki, and E. A. Clark. 1998. Different protein tyrosine kinases are required for B cell antigen receptor-mediated activation of extracellular signal-regulated kinase, c-Jun NH2-terminal kinase 1, and p38 mitogen-activated protein kinase. J. Exp. Med. 188: 1297-1306.
20. 2-terminal kinase, and p38 mitogen-activated protein kinase activation by the B cell antigen receptor. J. Exp. Med. 188: 1287-1295.
21. Zhang, C., N. Hirasawa, and M. A. Beaven. 1997. Antigen activation of mitogen-activated protein kinase in mast cells through protein kinase C-dependent and independent pathways. J. Immunol. 158: 4968-4975.
22. Kawakami, Y., S. E. Hartman, P. M. Holland, J. A. Cooper, and T. Kawakami. 1998. Multiple signaling pathways for the activation of JNK in mast cells: involvement of Bruton's tyrosine kinase, protein kinase C, and JNK kinases, SEK1 and MKK7. J. Immunol. 161: 1795-1802.
23. Campbell, K. S. 1999. Signal transduction from the B cell antigen-receptor. Curr. Opin. Immunol. 11: 256-264.
24. Siraganian, R. P. 2003. Mast cell signal transduction from the high-affinity IgE receptor. Curr. Opin. Immunol. 15: 639-646.
25. Yang, Y., L. Li, G. W. Wong, S. A. Krilis, M. S. Madhusudhan, A. Sali, and R. L. Stevens. 2002. RasGRP4, a new mast cell-restricted Ras guanine nucleotide-releasing protein with calcium- and diacylglycerol-binding motifs. J. Biol. Chem. 277: 25756-25774.
26. 2 in human and rat mast cell lines. J. Biol. Chem. 278: 4725-4729.
27. Rao, A., C. Luo, and P. G. Hogan. 1997. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15: 707-747.
28. Kalesnikoff, J., N. Baur, M. Leitges, M. R. Hughes, J. E. Damen, M. Huber, and G. Krystal. 2002. SHIP negatively regulates IgE + antigen-induced IL-6 production in mast cells by inhibiting NF-κB activity. J. Immunol. 168: 4737-4746.
29. Baranes, D., and E. Razin. 1991. Protein kinase C regulates proliferation of mast cells and the expression of the mRNAs of fos and jun proto-oncogenes during activation by IgE-Ag or calcium ionophore A23187. Blood 78: 2354-2364.
30. Srinivasula, S. M., M. Ahmad, J. H. Lin, J. L. Poyet, T. Fernandes-Alnemri, P. N. Tsichlis, and E. S. Alnemri. 1999. CLAP, a novel caspase recruitment domain-containing protein in the tumor necrosis factor receptor pathway, regulates NF-κB activation and apoptosis. J. Biol. Chem. 274: 17946-17954.
31. Koseki, T., N. Inohara, S. Chen, R. Carrio, J. Merino, M. O. Hottiger, G. J. Nabel, and G. Nunez. 1999. CIPER, a novel NF κB-activating protein containing a caspase recruitment domain with homology to Herpesvirus-2 protein E10. J. Biol. Chem. 274: 9955-9961.
32. Willis, T. G., D. M. Jadayel, M. Q. Du, H. Peng, A. R. Perry, M. Abdul-Rauf, H. Price, L. Karran, O. Majekodunmi, I. Wlodarska, et al. 1999. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 96: 35-45.
33. Zhang, Q., R. Siebert, M. Yan, B. Hinzmann, X. Cui, L. Xue, K. M. Rakestraw, C. W. Naeve, G. Beckmann, D. D. Weisenburger, et al. 1999. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat. Genet. 22: 63-68.
34. Ruland, J., G. S. Duncan, A. Elia, I. del Barco Barrantes, L. Nguyen, S. Plyte, D. G. Millar, D. Bouchard, A. Wakeham, P. S. Ohashi, and T. W. Mak. 2001. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-κB and neural tube closure. Cell 104: 33-42.
35. Xue, L., S. W. Morris, C. Orihuela, E. Tuomanen, X. Cui, R. Wen, and D. Wang. 2003. Defective development and function of Bcl10-deficient follicular, marginal zone and B1 B cells. Nat. Immunol. 4: 857-865.
36. Lin, X., and D. Wang. 2004. The roles of CARMA1, Bcl10, and MALT1 in antigen receptor signaling. Semin. Immunol. 16: 429-435.
37. Thome, M. 2004. CARMA1, BCL-10 and MALT1 in lymphocyte development and activation. Nat. Rev. Immunol. 4: 348-359.
38. Lanier, L. L. 2001. On guard-activating NK cell receptors. Nat. Immunol. 2: 23-27.
39. Klemm, S., J. Gutermuth, L. Hultner, T. Sparwasser, H. Behrendt, C. Peschel, T. W. Mak, T. Jakob, and J. Ruland. 2006. The Bcl10-Malt1 complex segregates FcεRI-mediated nuclear factor κB activation and cytokine production from mast cell degranulation. J. Exp. Med. 203: 337-347.
40. Wen, R., S.-T. Jou, Y. Chen, A. Hoffmeyer, and D. Wang. 2002. Phospholipase Cγ2 is essential for specific functions of FcεR and FcγR. J. Immunol. 169: 6743-6752.
41. Inagaki, N., T. Miura, H. Nagai, Y. Ono, and A. Koda. 1988. Inhibition of vascular permeability increase in mice: an additional anti-allergic mechanism of glucocorticoids. Int. Arch. Allergy Appl. Immunol. 87: 254-259.
42. Nagai, H., T. Sakurai, N. Inagaki, and H. Mori. 1995. An immunopharmacological study of the biphasic allergic skin reaction in mice. Biol. Pharm. Bull 18: 239-245.
43. Wen, R., Y. Chen, L. Xue, J. Schuman, S. Yang, S. W. Morris, and D. Wang. 2003. Phospholipase Cγ2 provides survival signals via Bcl2 and A1 in different subpopulations of B cells. J. Biol. Chem. 278: 43654-43662.
44. Wen, R., Y. Chen, J. Schuman, G. Fu, S. Yang, W. Zhang, D. K. Newman, and D. Wang. 2004. An important role of phospholipase Cγ1 in pre-B-cell development and allelic exclusion. EMBO J. 23: 4007-4017.
45. Dombrowicz, D., V. Flamand, K. K. Brigman, B. H. Koller, and J. P. Kinet. 1993. Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor α chain gene. Cell 75: 969-976.
46. Wershil, B. K., Z. S. Wang, J. R. Gordon, and S. J. Galli. 1991. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent: partial inhibition of the reaction with antiserum against tumor necrosis factor-α. J. Clin. Invest. 87: 446-453.
47. 2+ and purified isozymes in washed permeabilized cells. J. Biol. Chem. 268: 1749-1756.
48. Leinweber, B., A. M. Parissenti, C. Gallant, S. S. Gangopadhyay, A. Kirwan-Rhude, P. C. Leavis, and K. G. Morgan. 2000. Regulation of protein kinase C by the cytoskeletal protein calponin. J. Biol. Chem. 275: 40329-40336.
49. Ozawa, K., K. Yamada, M. G. Kazanietz, P. M. Blumberg, and M. A. Beaven. 1993. Different isozymes of protein kinase C mediate feedback inhibition of phospholipase C and stimulatory signals for exocytosis in rat RBL-2H3 cells. J. Biol. Chem. 268: 2280-2283.
50. 2+ responses and secretion in individual RBL-2H3 mucosal mast cells. J. Biol. Chem. 272: 31225-31229.
51. Nechushtan, H., M. Leitges, C. Cohen, G. Kay, and E. Razin. 2000. Inhibition of degranulation and interleukin-6 production in mast cells derived from mice deficient in protein kinase Cβ. Blood 95: 1752-1757.
52. Martiny-Baron, G., M. G. Kazanietz, H. Mischak, P. M. Blumberg, G. Kochs, H. Hug, D. Marme, and C. Schachtele. 1993. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J. Biol. Chem. 268: 9194-9197.
53. Millard, P. J., T. A. Ryan, W. W. Webb, and C. Fewtrell. 1989. Immunoglobulin E receptor cross-linking induces oscillations in intracellular free ionized calcium in individual tumor mast cells. J. Biol. Chem. 264: 19730-19739.
54. Franke, T. F., D. R. Kaplan, and L. C. Cantley. 1997. PI3K: downstream AKTion blocks apoptosis. Cell 88: 435-437.
55. Hemmings, B. A. 1997. Akt signaling: linking membrane events to life and death decisions. Science 275: 628-630.
56. Burgering, B. M., and P. J. Coffer. 1995. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376: 599-602.
57. Alessi, D. R., M. Andjelkovic, B. Caudwell, P. Cron, N. Morrice, P. Cohen, and B. A. Hemmings. 1996. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15: 6541-6551.
58. Boulton, T. G., S. H. Nye, D. J. Robbins, N. Y. Ip, E. Radziejewska, S. D. Morgenbesser, R. A. DePinho, N. Panayotatos, M. H. Cobb, and G. D. Yancopoulos. 1991. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65: 663-675.
59. Crews, C. M., A. Alessandrini, and R. L. Erikson. 1992. The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. Science 258: 478-480.
60. Akagi, T., T. Shishido, K. Murata, and H. Hanafusa. 2000. v-Crk activates the phosphoinositide 3-kinase/AKT pathway in transformation. Proc. Natl. Acad. Sci. USA 97: 7290-7295.
61. Salvador, J. M., P. R. Mittelstadt, T. Guszczynski, T. D. Copeland, H. Yamaguchi, E. Appella, A. J. Fornace, Jr., and J. D. Ashwell. 2005. Alternative p38 activation pathway mediated by T cell receptor-proximal tyrosine kinases. Nat. Immunol. 6: 390-395.
62. Zhang, C., R. A. Baumgartner, K. Yamada, and M. A. Beaven. 1997. Mitogen-activated protein (MAP) kinase regulates production of tumor necrosis factor-α and release of arachidonic acid in mast cells. Indications of communication between p38 and p42 MAP kinases. J. Biol. Chem. 272: 13397-13402.
63. Gershon, R. K., P. W. Askenase, and M. D. Gershon. 1975. Requirement for vasoactive amines for production of delayed-type hypersensitivity skin reactions. J. Exp. Med. 142: 732-747.
64. ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor. Cell 73: 611-620.
65. Chardin, P., J. H. Camonis, N. W. Gale, L. van Aelst, J. Schlessinger, M. H. Wigler, and D. Bar-Sagi. 1993. Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. Science 260: 1338-1343.
66. Hirasawa, N., A. Scharenberg, H. Yamamura, M. A. Beaven, and J. P. Kinet. 1995. A requirement for Syk in the activation of the microtubule-associated protein kinase/phospholipase A2 pathway by FcεRI is not shared by a G protein-coupled receptor. J. Biol. Chem. 270: 10960-10967.
67. Turner, H., and D. A. Cantrell. 1997. Distinct Ras effector pathways are involved in FcεRI regulation of the transcriptional activity of Elk-1 and NFAT in mast cells. J. Exp. Med. 185: 43-53.
68. Wang, D., J. Feng, R. Wen, J. C. Marine, M. Y. Sangster, E. Parganas, A. Hoffmeyer, C. W. Jackson, J. L. Cleveland, P. J. Murray, and J. N. Ihle. 2000. Phospholipase Cγ2 is essential in the functions of B cell and several Fc receptors. Immunity 13: 25-35.
69. Marquardt, D. L., and L. L. Walker. 2000. Dependence of mast cell IgE-mediated cytokine production on nuclear factor-κB activity. J. Allergy Clin. Immunol. 105: 500-505.
70. Lee, Y.-N., J. Tuckerman, H. Nechushtan, G. Schutz, E. Razin, and P. Angel. 2004. c-Fos as a regulator of degranulation and cytokine production in FcεRI-activated mast cells. J. Immunol. 173: 2571-2577.